J ugular foramen paragangliomas (JFPs) are rare, slowgrowing, typically benign tumors of the paraganglia within the adventitia of the jugular bulb. 5, 15 These lesions account for 0.6% of head and neck tumors and 80% of jugular foramen tumors. 32 JFPs can infiltrate along the tympanic canaliculus, invading superiorly toward the middle ear and inferiorly into the jugular fossa.
decades and have benefited from refinements and advances in surgical techniques. 28, 32, 49 Surgery-related mortality has dramatically decreased, from 22% 28 to nearly 0% in most studies. 3, 38 The majority of JFPs were treated and reported by otolaryngology-head and neck surgeons, [4] [5] [6] 10, 11, [16] [17] [18] [19] 28, 30, 32, 40, [49] [50] [51] [52] 55, 56 but relatively few by neurosurgeons. 1, 2, 31, 35, 41, 43 Often JFPs were reported together with glomus tumors of other regions and, less frequently, with subdural invasion, 49, 50 although JFPs are inherently distinct from other glomus tumors in terms of surgical difficulty and outcomes. In the present study, we reviewed our less-aggressive treatment strategy and neurosurgical experience in JFPs to achieve satisfactory neurological outcome.
methods
The study included 51 consecutive cases of JFPs (24 male patients, 47.1%; 27 female patients, 52.9%; M/F ratio of 1:1.1) that were surgically treated in Beijing Tiantan Hospital between February 1993 and February 2013. Clinical charts and radiographic data were reviewed retrospectively. The Karnofsky Performance Scale (KPS) was used to evaluate pre-and postoperative neurological status; pre-and postoperative facial nerve function was assessed with the House-Brackmann scale; hearing function was evaluated according to the Gardner-Robertson hearing scale; and swallowing function was evaluated based on the dysphagia index. 6 The Beijing Tiantan Hospital Research Ethics Committee approved the study.
radiographic examination
Preoperative and postoperative skull base CT and brain MRI (T1-and T2-weighted sequences, and contrast enhancement) with or without MR venography were performed in all patients. In the majority of patients with a large lesion size and notable flow void, digital subtraction angiography was required (in 41 patients [80.4%]) to identify the feeding arteries and to perform selective embolization if feasible. Lesion size was evaluated as the lesion equivalent diameter (abc) 1/3 , where a, b, and c represented the diameters as measured on axial, sagittal, and coronal MR images, respectively. The mean lesion size was 3.8 ± 1.3 cm (range 1.3-7.0 cm). (The mean is expressed ± SD throughout.) In the Fisch classification, 10, 11, 58 there were 8 cases of Type C (15.7%; Type C1 in 1 case, Type C2 in 4 cases, and Type C3 in 3 cases) and 43 cases of Type D (84.3%; Type De1 in 3 cases, Type De2 in 3 cases, Type Di1 in 13 cases, and Type Di2 in 24 cases). In the Glasscock-Jackson classification, [16] [17] [18] the numbers of Types I, II, III, and IV were 3 (5.9%), 11 (21.6%), 19 (37.3%), and 18 (35.3%) cases, respectively.
Postoperative CT scans were performed within 24 hours and MRI with contrast and fat-suppression sequence within 72 hours to evaluate the resection. Gross-total resection (GTR) was defined as total removal of the lesion without residual tumor on the MRI; subtotal resection (STR) was defined as 95%-99% of the quantified lesion volume removed; and partial resection (PR) as less than 95% of the lesion removed. Based on contrast-enhanced MRI scans with or without a fat-suppression sequence obtained in the follow-up period, new onset of a contrast-enhanced lesion in situ after GTR was considered to be tumor recurrence; an increase of lesion size ≥ 2 mm after non-GTR was considered to be tumor regrowth; and disappearance of lesion, change of lesion size < 2 mm, or decrease of lesion size after radiotherapy were considered to be recurrence/ regrowth (R/R)-free.
surgical management
The surgical approach was selected based on lesion size, main lesion location, regions invaded by JFPs, previous treatment, surgical goal, patients' wishes and neurological status, and surgeon preference. Surgical approaches included the following: the far-lateral paracondylar approach in 36 patients (70.6%); the far-lateral supracondylar approach in 10 (19.6%); the far-lateral transcondylar approach in 2 (3.9%); and the submandibular approach in 1 (2.0%), retrosigmoid combined with the supratentorial and infratentorial approach in 1 (2.0%), and far-lateral combined with the supratentorial and infratentorial approach in 1 (2.0%). Although the latter 2 combined surgical approaches, which were performed in the early period of our series (before 1998), seemed aggressive, the preservation of vital neurovascular structures was stressed throughout these approaches. Intraoperative electrophysiological monitoring (somatosensory evoked potential, motor evoked potential, and monitoring of lower cranial nerves [LCNs]) was applied routinely. The external carotid artery (ECA) was or was not ligated based on the feeding arteries, angiographic blush, and patient's status.
Because most lesions were located in the jugular foramen with both intracranial and extracranial invasion, a far-lateral paracondylar or supracondylar approach was preferred. The advantages were as follows: 1) providing sufficient exposure of intracranial and extracranial space surrounding the jugular foramen; 2) preservation of semicircular canals and efficient hearing; 3) little manipulation of or influence on cranial nerve (CN) VII and its function; 4) short distance to access JFPs; 5) meticulously removing bone structure surrounding the jugular foramen to preserve the anatomical structure and functions of LCNs; and 6) removing lesions involving the internal carotid artery (ICA) safely along the surgical approach. Transposition of the vertebral artery (VA) was unnecessary unless the extradural VA was involved. 49 Infiltrated air cells were removed if possible to decrease R/R.
The essential goals of the less-aggressive strategy included endeavoring to preserve neurovascular structures (epineurium and perineurium of CNs, and adventitia of vital arteries); sparing the infiltrated medial wall of the jugular bulb to preserve LCNs; removing only the subperiosteal tumor surrounding the ICA rather than the already invaded adventitia; abandoning GTR if remarkable changes were presented with neuromonitoring; and performing GTR only if there was no adherence to critical structures or if effortless/blunt dissection was sufficient to peel off the tumor. The actual goal of less-aggressive surgical management was maximal preservation of neurological function and minimal surgical morbidity rather than a small surgical incision, because the surgical approach should conform to lesion features to obtain sufficient access to the lesion and to provide adequate surgical freedom. Meanwhile, surgical approach-related complications were usually transient, curable, and acceptable.
pathology, Follow-up, and radiotherapy
Two neuropathologists reviewed immunohistochemical examinations, including WHO grade and number of pathological mitoses (Ki 67) per 10 hpf. Lesions were divided into 2 groups: no mitosis, and ≥ 1 mitosis per 10 hpf. Follow-up was conducted via clinic visit, telephone interview, and/or mailed questionnaire.
Radiotherapy was recommended for patients with non-GTR, pathological mitosis, or anaplastic JFPs; however, patients with previous radiotherapy were followed up with observation and scheduled radiographic reexaminations at 3, 6, and 12 months, and then once per year thereafter. Continuing observation was preferred to radiotherapy if residual lesions did not progress. Eleven patients (21.6%) received postoperative adjuvant radiotherapy: Gamma Knife surgery (GKS) for 9 patients (17.6%), and X-knife and linear accelerator therapy for 1 patient each. Two patients received radiotherapy for R/R: GKS in one patient, and both GKS and CyberKnife in the other patient.
In the 11 GKS procedures that were performed in our institute, a Leksell Gamma Knife Model B (Elekta AB) was used between 1994 and 2000; from 2000 on, Model C was used. Before May 1996, the Kula planning system (Elekta AB) was used; thereafter, Leksell Gamma Plan software (Elekta AB) was used. Given the clear delineation of the tumor margin on MRI scans, all tumors had total coverage with stereotactic radiation. Treatment planning was designed using irradiation to multiple isocenters to achieve better conformity between the treatment volume and the tumor volume. The mean tumor volume was 4.6 ml (range 0.7-8.5 ml). The mean number of isocenters was 20 (range [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . The mean marginal dose was 13.1 Gy (range 11.5-14.0 Gy), at a mean isodose level of 50.8% (range 48.8%-55.5%). The mean maximum intralesional radiation dose was 25.7 Gy (range 23.0-28.0 Gy). Information about the radiosurgical technique of X-knife and CyberKnife performed in other institutions was not available, but the data regarding dose were obtained. In the patient receiving X-knife therapy, the marginal dose, maximum tumor dose, isodose level, and tumor volume was 14.5 Gy, 22.0 Gy, 65.9%, and 3.7 ml, respectively, and in the patient receiving Cyberknife therapy those values were 15.0 Gy, 25.0 Gy, 60.0%, and 8.7 ml, respectively. The total dose of radiation delivered in the patient receiving linear accelerator therapy was 45 Gy in 25 fractions.
statistical analysis
Statistical analysis was performed using IBM SPSS (version 19.0) statistical analysis software, and p < 0.05 was considered statistically significant. Due to the small number of patients in our study, the Fisch classification of JFPs was divided into 2 groups: Type Di2 and other types; the Glasscock-Jackson classification was classified into Type I-II and Type III-IV; resection was divided into GTR and non-GTR groups; preoperative and postoperative KPS scores were grouped into KPS < 80 and KPS ≥ 80. The Cox proportional hazard regression model was used to analyze risk factors for tumor R/R. Binary logistic regression analysis was used to identify risk factors for poor neurological outcome (KPS < 80).
results
The mean duration of symptoms was 48.6 ± 46.0 months (range 1.3-252 months), and the mean age on admission was 41.6 ± 11.7 years (range 10-61 years). Thirteen patients (25.5%) had undergone previous treatment: resection (n = 12); GKS (n = 3); conventional radiotherapy (n = 2); X-knife (n = 1); and interventional embolization (n = 1). Preoperative symptoms on admission are detailed in Table 1 . The mean preoperative KPS score was 78.4 ± 7.7 (range 60-90): KPS scores of 90, 80, 70, and 60 were found in 9 (17.6%), 26 (51.0%), 14 (27.5%), and 2 (3.9%) patients, respectively. We stratified the clinical data according to the different management strategies for feeding arteries (Table 2) , and found that only lesion size was significantly different between these 3 groups (p < 0.001).
Intraoperatively, the external auditory meatus was permanently closed in 5 patients (9.8%), and adhesion to brainstem was found in 5 (9.8%) cases. The mean operation time was 7.9 ± 2.6 hours (range 2.3-14.0 hours) and the mean blood loss was 3057.8 ± 1934.6 ml (range 300-8000 ml). A GTR was achieved in 26 (51.0%) patients, an STR in 22 (43.1%), and a PR in 3 (5.9%). WHO Grade I JFPs were identified in 49 (96.1%) cases, and WHO Grade III (anaplastic) JFPs were found in 2 (3.9%) cases. Immunohistochemical staining found mitosis in 14 cases (27.5%) and infiltrative or active growth in 5 and 4 cases, respectively.
surgical morbidity
Surgical morbidities occurred in 23 patients (45.1%), including 14 patients (53.8%, 14/26) from the GTR cohort and 9 patients (40.9%, 9/22) from the STR cohort. There was no surgery-related mortality after the first operation. New-onset facial palsy and dysphagia were observed in 13 (25.5%) and 10 (19.6%) patients, respectively (Table 1) , and other minor new/worsened neuropathies included hearing deficit (n = 3, 5.9%), tinnitus (n = 1, 2.0%), hoarseness (n = 8, 15.7%), weakened gag reflex (n = 6, 11.8%), dysdipsia (n = 12, 23.5%), CN XI deficit (n = 3, 5.9%), glossal deviation (n = 4, 7.8%), and glossal atrophy (n = 3, 5.9%). Because of dysphagia or dysdipsia, 12 patients (23.5%) needed nasal feeding.
Other complications included CSF leakage (n = 7, 13.7%), intracranial infection (n = 4, 7.8%), pneumonia (n = 2, 3.9%), and deep venous thrombosis (n = 1, 2.0%). Six patients (11.8%) underwent tracheostomies and 3 patients (5.9%) with respiratory disorders required ventilators.
short-term surgical outcomes
The postoperative evaluation at discharge revealed KPS scores of 80, 70, 60, 50, and 40 in 19, 23, 6, 2, and 1 of the patients, respectively. The mean KPS score of 71.8 ± 8.0 (range 40-80) was significantly worse than the preoperative KPS score (p < 0.001). Neurological status improved in 2 patients (3.9%), was unchanged in 21 (41.2%), and worsened in 28 (54.9%). The mean KPS scores at 3 months and 1 year were 77.2 ± 7.0 and 83.2 ± 6.5, respectively ( Fig. 1 ).
recurrence and long-term Functional outcomes
After a mean follow-up duration of 85.7 ± 55.4 months (range 23.2-219.3 months), long-term follow-up was conducted with 46 patients (90.2%). In 5 patients (9.8%) who were lost to long-term follow-up, the available mean follow-up duration was 49.7 months. Recurrence/regrowth occurred in 6 patients, and the mean duration of R/R-free survival was 53.8 ± 36.7 months. The overall R/R-free survival at 5, 10, and 15 years was 90.8%, 78.9%, and 78.9%, respectively (Fig. 2) . Treatment modalities for R/R are described in Table 3 . Tumor control was favorable in the 2 patients receiving radiosurgery, without symptom progression thereafter; however, the other 4 patients suffered from relentless tumor growth, and ultimately 1 patient died of intracranial hematoma after 2 operations, and 3 patients died of tumor R/R without treatment. The mean symptom progression-free survival duration of the 6 patients was 67.8 ± 48.9 months. The overall symptom progressionfree survival at 5, 10, and 15 years was 93.5%, 86.8%, and 86.8%, respectively (Fig. 2) .
Regarding swallowing function, in 16 patients (31.4%) with aggravating dysphagia after surgery, 3 patients improved to better than their preoperative status, 11 patients recovered to their baseline, and 2 patients fell below their preoperative status. Follow-up swallowing function is detailed in Table 1 . Compared with preoperative status, swallowing function improved in 7 patients (13.7%), stabilized in 42 patients (82.3%), and worsened in 2 patients (3.9%). Regarding CN VII in 15 patients (29.4%) with new-onset/ worsened facial palsy, the House-Brackmann scale grade improved in 2 patients compared with the preoperative grade and stabilized in 10 patients, and the remaining 3 patients still had varying grades of facial palsy. Overall, facial function was rated as Grade I/II and III/IV in 43 (84.3%) and 8 (15.7%) patients, respectively. As a whole, CN VII function improved in 16 patients (31.4%), did not change in 32 patients (62.7%), and worsened in 3 patients (5.9%).
The mean recent KPS score was 79.6 ± 24.4 (range 0-100) (Table 4) , which was similar to the preoperative score (78.4, p = 0.726) and significantly better than the postoperative score (71.8, p = 0.012). The overall survival at 5, 10, and 15 years was 95.1%, 80.6%, and 80.6%, respec- (Figs. 3 and 4) . After adjustment for age and sex in a multivariate Cox model, only mitosis (HR 10.640, 95% CI 1.82-62.2, p = 0.009) was confirmed as an independent risk factor for R/R of JFPs (Fig. 3) .
Univariate logistic regression revealed a preoperative KPS score < 80 (p = 0.026) as a risk factor for poor outcome; by coincidence, the potential adverse predictor of a 1-year increase in age (p = 0.050) was approximately the threshold value. In the multivariate logistic model with adjustment for age and sex, a 1-year increase in age (OR 1.12, 95% CI 1.01-1.23, p = 0.037) and preoperative KPS score < 80 (OR 11.1, 95% CI 1.52-80.6, p = 0.018) were demonstrated as independent risk factors for poor outcomes (Table 5) .
discussion
Although the majority of JFPs were benign, aggressive growth led to severe and formidable symptoms and contributed to challenging surgical management. Fig. 1 . Box plot illustrating pre-and postoperative KPS scores evaluated at different periods. Postoperative KPS score at discharge significantly decreased and gradually ascended during follow-up. The KPS score at 3 months improved, and was similar to the preoperative score. The KPS score at 1 year and at the most recent evaluation was better than the preoperative score. Circles indicate outliers. observation 5, 7 have been reported previously as alternative options for patients who have unresectable JFPs or who are poor candidates for surgery, including those with asymptomatic lesions, elderly patients with serious comorbidities or contraindications, and patients rejected for surgery due to surgical risks. Recently, Ivan et al. 21 and Suárez et al. 52 logically recognized that the meta-analysis was limited by the heterogeneity (confounding bias; i.e., lesion size), quality, and accuracy of these studies after thoroughly reviewing pertinent literature to investigate the efficacy and safety of different treatment modalities for JFPs. 4, 52 Except for these aforementioned conservative approaches, surgical treatment had been confirmed to be a definitive and convincing strategy that offers the only chance of a cure. 9, 19, [22] [23] [24] [25] [26] 28, 32, 41, 48, 52, 55 In our hospital, the aim of surgery was the maximal elimination of JFPs and the preservation of neurological function. A GTR was an ideal tactic that was attempted, with accompanying morbidity; meanwhile, STR plus radiotherapy was a second option with relatively low functional impairment. If lesions were troublesome, including those with intractable intraoperative bleeding, encasement of vital vessels, and strong adhesion to neurovascular structures that could not be separated easily, complete removal without morbidity was theoretically impossible, and a planned STR was favored to retain CN function. 4, 56 Based on our study over the course of 20 years, we focused on the neurological preservation and found that 1) less than 6% of patients suffered from worsened facial and swallowing function; 2) overall neurological status improved or stabilized in 90.0% of patients; 3) overall R/Rfree survival, symptom progression-free survival, and overall survival at 15 years were 78.9%, 86.8%, and 80.6%, respectively; 4) poor preoperative status and increased age at surgery were risk factors for poor functional outcome; and 5) pathological mitosis predicted R/R. These results indicated that 1) surgical morbidities were acceptable because most were temporary and improved during followup; 2) a less-aggressive surgical approach was feasible to preserve neurological function, and maximal decompression with radiotherapy rather than radical resection could be advocated; 3) early surgery was recommended to candidates for surgery; and 4) pathological mitosis justified radiotherapy. To better understand JFPs, their natural history, surgical outcomes, and our experience are discussed below.
natural history and radiotherapy
The natural history reported in previous studies was undetermined. Some authors insisted on a low-risk approach, but relentless radiological growth was observed in up to 42% of JFPs from a natural history study. 5 An older subset of patients was not exceptional. The phenomena of benign behavior or growth arrest were not necessarily parallel in all populations. A large number of lesions would progress into the advanced stage with clinical deterioration under observation, and we speculated that the rate of progression would rise in younger participants and with lifelong observation. 48 Based on the pooled data of 339 JFPs, patients undergoing stereotactic radiosurgery had a tumor control of 95%. 21 It should be noted that studies of natural history and radiotherapy had an inherent selection bias and did not include all types of patients. Most of these studies were limited by short-term follow-up (the median follow-up ranged from 9.7 to 49 months, 20, 39, 46 and the mean follow-up ranged from 44.6 to 48 months 56, 58 ); elderly patients (the mean age ranged from 56.9 to 74.5 years, 7, 52 and the median age ranged from 55 to 69.6 years 5, 46, 58 ); and relatively small lesions (median volume 15.8 ml 20 or mean size 2.6 cm 21 ). A biased research design unjustly favored the indolent biology of JFPs and the validity of radiotherapy. Radiation was incorrectly preferred as a primary strategy, and surgery was mistaken as a salvage procedure. If the lesion grew to a size that justified resection, the difficulty of the operation would increase due to radiation-induced fibrosis and adhesion. Therefore, radiotherapy and observation could be recommended for patients assumed to have a relatively limited life expectancy, rather than for small lesions that most likely could be removed surgically without complications. Meanwhile, radiotherapy was reasonable for elderly patients, in whom the risk of late recurrence or complications might exceed life expectancy.
management philosophy and less-aggressive strategy
Although there was no consensus on the management of JFPs, most studies have favored complete resection as much as possible. 2, 9, 28, 44, 48, 49 In a few selected patients, planned STR and a less-aggressive strategy was adopted to preserve patients' neurological functions. 56 One single operation 1,27,29 was preferred to a staged operation 32, 33, 38, 42, 49, 50 regardless of intradural size; there were no widely accepted criteria for staged surgery. Sivalingam et al. 50 performed staged surgery in 35.6% of patients to achieve devascularization and subsequent shrinkage of intradural masses that theoretically made cleavage between the tumor and brainstem easy to establish, whereas in our experience this strategy was unnecessary because the adhesion between the brainstem and tumor was only found in 5 cases (9.8%). A CSF leak was a serious but not catastrophic complication that was treatable via lumbar drainage, 1, 35 and it was not serious enough to advocate staged surgery. 29, 32, 49, 50 Compared with the study by Sivalingam et al., in which a CSF leak rate of 4.4% (2/45) was reported, Ramina and colleagues [43] [44] [45] detailed their experience in skull base reconstruction with the watertight closure technique, and their CSF leak rate (4.3%) was similar to that in the other study (4.4%).
Surgery was recommended soon after diagnosis, rather than being delayed until patients became terminally ill with significantly swelling lesion volumes. 57 We found that the long-term outcome was closely related to preoperative status and patients' age on admission, and for these reasons early surgical intervention gives a greater chance of preservation of LCN function compared with later surgery. In some JFPs of large size and extreme vascularization, preoperative embolization was imperative to reduce intraoperative hemorrhage and ease resection. For candidates in whom embolization was not recommended or for patients with an economic burden, ligation of the ECA was recommended and was performed in 16 of our patients (Table 2) , in contrast to the statement by Sanna et al. 49 that it was of utmost importance to reserve that procedure for a potential recurrence or an intradural lesion before the planned second-stage surgery. We confirmed that preoperative devascularization was needed to reduce surgical difficulty and to facilitate overall GTR. The use of intraoperative ultracautery instead of devascularization to shrink the lesion was inadvisable, and would risk LCNs due to thermal injury. Similarly, Makiese et al. 35 performed both preoperative balloon occlusion tests and embolization in 100% of patients, and blood loss was negligible, with a mean of 380 ml.
According to the theory of nerve injury proposed by Sunderland 53 and Makek et al., 34 neural infiltration occurred frequently without preoperative dysfunction because the slow growth and gradual loss of neural function allowed patients to compensate. 6 It was speculated that clinical dysfunction was not noted until a high percentage of neurons were damaged. Therefore, serious loss of function might be encountered immediately after a slight dissection of lesions within the pars nervosa. 6 In cases of perineural invasion, decompression was indicated. The intrabulbar tumor removal technique was initially elucidated by Gejrot 13 and later by Al-Mefty and Teixeira 1 to preserve the medial wall of the jugular bulb, internal jugular vein, and LCNs. 32 According to our observations, the infiltrated LCNs should not be sacrificed to pursue GTR unless the LCNs had already been completely deprived of their function as judged by preoperative evoked potential. The remaining tumors were treated with radiation because of their satisfactory responses to radiotherapy and their low regrowth rate. 6, 12, 14, 37 Cheesman and Kelly 6 detailed surgical salvage as subsequent rehabilitation for LCN neuropathy if necessary, which would be beneficial to patients. Briefly, given the absence of guidelines, we favored early, 1-stage surgery as a less-aggressive strategy, accompanied with preoperative devascularization, subsequent radiotherapy, and rehabilitation if needed to optimize prognosis.
neurological Function outcomes and risks
Neurological outcome varied based on lesion classifications, surgeons' experience, and surgical approaches.
2,42,43
The distribution of Fisch classifications varied among studies and disciplines. Reported Type Di2 lesions accounted for only 2.9%-7.7%, 9,41,55 or 25.9% 32 in a recent large otolaryngological study, which was significantly lower than other neurological studies (38.2%) 2 and our own findings (47.1%). If intracranial extension was involved, the percentage of lesions classified as Fisch Type D was calculated as 18.7% in 530 lesions, 21 and our value (84.3%) was also higher than in other studies (range 33%-72%). 19, 28, 36, 38, 47 The severity of intracranial extension and ICA involvement were proven to be significant influential factors for resection. 32 If both the ICA and pars nervosa were infiltrated, GTR without morbidity was extremely challenging, especially in previously treated or irritated lesions. The pooled rates of neuropathy after GTR in CNs IX, X, XI, and XII were estimated at 38%, 26%, 40%, and 18%, respectively. 21 Jackson et al. 28 routinely resected CN IX for adequate exposure of the ICA, which resulted in new deficits in CNs IX, X, XI, and XII in 57%, 40%, 62%, and 54% of cases, respectively, and their GTR was accomplished at the expense of LCN function. The priority of neurological function could be maintained via planned STR and, as a result, the GTR rate (51%) in our group was compromised and was lower than in most previous studies (from 73.3% 31 to 91%).
The aggravated facial palsy and dysphagia following removal of JFPs were detrimental to the patients' quality of life. Facial asymmetry was a morbidity that was obvious to both doctors and patients. Preservation of facial status to House-Brackmann Grade I/II was reported as ranging from 65.8% to 95% after varied facial management strategies; 19, 36, 38, 47 however, the actual percentage of worsened facial status was at least 34.6%-66.7%. 19, 47 A less-invasive transjugular approach with a fallopian bridge technique provided adequate tumor resection and a definitive advantage over a more extensive approach in that it did not induce facial palsy. 41 The function-preserving therapy appeared to offer the greatest benefit. 30 Moreover, radical removal could be achieved without facial rerouting. In the study by Borba et al., who focused on facial nerve preservation and neuroanastomosis, only 8.8% of patients had worsened facial palsy and the others (91.2%) were improved or unchanged, which was a result similar to that of Makiese et al. 35 (90.7%). Facial morbidity occurred in 15 of our patients (29.4%) immediately after surgery, which was similar to findings in the study by Liu et al. 31 (26.7%) and House Ear Institute data (29.8%). 9 Fortunately, 84.3% of all patients had acceptable status (Grade I/II), 12 patients had transient status, and only 3 patients (5.9%) had permanent damage, which was comparable to a previous study (7.1%). 1 Dysphagia was generally an underrecognized morbidity unless it was decompensated, resulting in aspiration. 6 Complicated dysphagia was reported in 27.1% of patients. 9 At a recent evaluation of our group, the swallowing function was satisfactory in 96.1% of patients (Grade 0/1) ( Table 1) and worsened in 2 patients (3.9%). No patient requested any special treatment or gastrostomy for dysphagia except 1, who continued to require nasal feeding. Patients developed feasible coping measures to overcome the deficit by selecting food of a specific consistency and size that were suitable, prolonging meal duration, or changing body position when eating. With a multidisciplinary approach, both postoperative new facial and LCN deficits could be reduced to 6.6%. 35, 43 To further improve the preservation of CNs and minimize surgical morbidities, we have dedicated ourselves to establishing a multidisciplinary collaboration in skull base surgery over the past 5 years. With regard to overall neurological function, our recent KPS score of ≥ 80 in 88.0% patients (excluding the patient who died of unrelated causes) was comparable to 91.7%, 42 92.5%, 43 or 93.9% 2 in previous studies, regardless of the follow-up duration. The outcome was favorable, with at least 85% of patients being able to fully resume all preoperative activities. 2, 19 The regrowth rate following incomplete resection ranged from 17% to 33.3%, 3, 28, 43, 54, 56 regardless of followup time. The estimated tumor control rates after GTR and STR were 86% and 69%, respectively, and the rate increased to 71% for STR plus radiotherapy. 21 We found that non-GTR increased the R/R rate (20.0%) nearly 5-fold over GTR (3.8%); however, the difference was not statistically significant (Fig. 3 ) and might be limited by the small size of the patient cohort. Given the notable differences in sex and age distributions, we failed to prove an association between either age or sex and R/R that was equal to the results summarized by Ivan et al., 21 who excluded both age and sex as potential confounders. The possibility of Fisch types related to the R/R had not been addressed previously, and we found that the Type Di2 lesions predicted R/R in a univariate analysis (Fig. 3, and Fig. 4 left) but were insignificant after adjustment for sex and age. As stated by Lope Ahmad et al., 32 GTR would possibly be compromised by increased intracranial invasion that risked R/R in the future. Finally, we emphasized the remarkable effect of mitosis on lesion R/R both before and after adjustment for age and sex (Fig. 4 right) , and therefore, adjuvant radiotherapy was strongly recommended to patients with pathological mitosis even after radical resection. Close surveillance and radiological follow-up were necessary, and proactive treatment (surgery or radiotherapy) was necessary for recurrent cases.
conclusions
Favorable long-term functional outcome of JFPs could be achieved via a 1-stage, less-aggressive surgical strategy. The majority of patients with CN deficits could tolerate and overcome surgical morbidities and could carry out normal life activities. Maximal decompression with or without radiotherapy was an alternative to preserve patient quality of life when radical resection was not warranted. Based on the risks of poor functional outcome, we proposed early surgery plus preoperative devascularization. Radiotherapy was mandatory for lesions with pathological mitosis or after incomplete resection.
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